ClinicalTrials.Veeva

Menu

The Relative Effects of Olmesartan Medoxomil, Irbesartan and Valsartan on the Activity of the Blood Pressure Control System in Healthy Subjects

Daiichi Sankyo logo

Daiichi Sankyo

Status and phase

Completed
Phase 4

Conditions

Healthy

Treatments

Drug: Olmesartan medoxomil
Drug: Valsartan
Drug: Irbesartan

Study type

Interventional

Funder types

Industry

Identifiers

NCT00185055
866-448

Details and patient eligibility

About

To assess the effects of 3 blood pressure drugs, called angiotensin receptor blockers, on the blood pressure control systems in healthy subjects.

Sex

All

Ages

18 to 65 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Men and women between the ages of 18 to 65
  • In good health

Exclusion criteria

  • Any serious health problems
  • Positive test for HIV, Hepatitis B and C
  • History of drug and alcohol abuse

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Crossover Assignment

Masking

Single Blind

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems